Design and synthesis of sorafenib-inspired benzofuran hybrids as VEGFR-2 inhibitors: antiproliferative evaluation, mechanistic insights, and docking studies in hepatocellular carcinoma
{{output}}
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide owing to its high metastatic potential. Vascular endothelial growth factor receptor-2 (VEGFR-2), a key regulator of angiogenesis and cell proliferation, is a critical thera... ...
